Top Markets
Coin of the day
Cellivery Therapeutics, Inc. Cellivery Therapeutics, Inc.

Cellivery Therapeutics, Inc.

268600
Rank in Stocks #19185
Cellivery Therapeutics, Inc. is dedicated to pioneering therapeutic drugs... Cellivery Therapeutics, Inc. is dedicated to pioneering therapeutic drugs designed to combat critical and often fatal conditions, including various cancers, inflammatory disorders, metabolic diseases, and neurodegenerative ailments. The company leverages its proprietary Therapeutic molecule Systemic Delivery Technology to develop a diverse pipeline of small molecule compounds, antibodies, and vaccines. Established in 2014, this firm is headquartered in Seoul, South Korea.
Share Price
$4.62
Last synced: 2023-03-23
Market Cap
$171.76M
Change (1 day)
-37.16%
Change (1 year)
0.00%
Country
KR
Trade Cellivery Therapeutics, Inc. (268600)

Category

Price of 268600 with the market cap of B
Cellivery Therapeutics, Inc. Cellivery Therapeutics, Inc.
268600
$4.62
Market Capitalization of Cellivery Therapeutics, Inc.(268600)
Market Cap: $171.76M
As of August 2026 Cellivery Therapeutics, Inc. has a market cap of $171.76M. This makes Cellivery Therapeutics, Inc. the world's 19185th most valuable company by market cap according to our data. The market capitalization, commonly called market cap, is the total market value of a publicly traded company's outstanding shares and is commonly used to measure how much a company is worth.
Market cap history of Cellivery Therapeutics, Inc. from 2018 to 2026
268600 compared with Top 5 Most Popular stocks
Price of 268600 Asset B Mkt. of B Results
Cellivery Therapeutics, Inc. Cellivery Therapeutics, Inc.
$138,570 $171.76M
$5.152T +2,999,785.97%
Cellivery Therapeutics, Inc. Cellivery Therapeutics, Inc.
$122,018 $171.76M
$4.537T +2,641,448.56%
Cellivery Therapeutics, Inc. Cellivery Therapeutics, Inc.
$112,109 $171.76M
$4.169T +2,426,927.41%
Cellivery Therapeutics, Inc. Cellivery Therapeutics, Inc.
$97,956.71 $171.76M
$3.642T +2,120,552.71%
Cellivery Therapeutics, Inc. Cellivery Therapeutics, Inc.
$75,429.19 $171.76M
$2.805T +1,632,857.36%